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Asymmetric ﬂuid ﬂows generated by motile cilia in a transient ‘organ of asymmetry’ are involved in
establishing the left–right (LR) body axis during embryonic development. The vacuolar-type Hþ-ATPase
(V-ATPase) proton pump has been identiﬁed as an early factor in the LR pathway that functions prior to
cilia, but the role(s) for V-ATPase activity are not fully understood. In the zebraﬁsh embryo, the V-ATPase
accessory protein Atp6ap1b is maternally supplied and expressed in dorsal forerunner cells (DFCs) that
give rise to the ciliated organ of asymmetry called Kupffer’s vesicle (KV). V-ATPase accessory proteins
modulate V-ATPase activity, but little is known about their functions in development. We investigated
Atp6ap1b and V-ATPase in KV development using morpholinos, mutants and pharmacological inhibitors.
Depletion of both maternal and zygotic atp6ap1b expression reduced KV organ size, altered cilia length
and disrupted LR patterning of the embryo. Defects in other ciliated structures—neuromasts and olfac-
tory placodes—suggested a broad role for Atp6ap1b during development of ciliated organs. V-ATPase
inhibitor treatments reduced KV size and identiﬁed a window of development in which V-ATPase activity
is required for proper LR asymmetry. Interfering with Atp6ap1b or V-ATPase function reduced the rate of
DFC proliferation, which resulted in fewer ciliated cells incorporating into the KV organ. Analyses of pH
and subcellular V-ATPase localizations suggested Atp6ap1b functions to localize the V-ATPase to the
plasma membrane where it regulates proton ﬂux and cytoplasmic pH. These results uncover a new role
for the V-ATPase accessory protein Atp6ap1b in early development to maintain the proliferation rate of
precursor cells needed to construct a ciliated KV organ capable of generating LR asymmetry.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
It is well established that a conserved Nodal signaling cascade
activated in left lateral plate mesoderm guides development of
left–right (LR) asymmetries in the cardiovascular and gastro-
intestinal systems (Hamada et al., 2002; Raya and Izpisua Bel-
monte, 2006; Yost, 1999). Defects in establishing these asymme-
tries can result in a broad spectrum of birth defects, which often
include congenital heart malformations (Maclean and Dunwoodie,
2004; Ramsdell, 2005). In several vertebrates, proper asymmetric
Nodal expression depends on motile cilia generating ﬂuid ﬂows
(Blum et al., 2014) that have been proposed to asymmetrically
distribute signaling molecules (Nonaka et al., 1998; Tanaka et al.,
2005) and/or activate sensory cilia (McGrath et al., 2003; Yoshiba
et al., 2012). These cilia are found on transient epithelial tissues in
the ventral node and posterior notochord of mouse (Blum et al.,
2007; Nonaka et al., 1998), gastrocoel roof plate of frog(Schweickert et al., 2007), and Kupffer’s vesicle (KV) of medaka
(Okada et al., 2005) and zebraﬁsh (Essner et al., 2005; Kramer-
Zucker et al., 2005) embryos. Mutations disrupting these struc-
tures, which we refer to as the ‘organ of asymmetry,’ result in
altered asymmetric Nodal signaling and LR defects. While steps of
the LR pathway downstream of cilia-driven ﬂow have received
much attention, developmental events that precede cilia function
are still poorly understood.
The zebraﬁsh KV provides a useful model to investigate early
developmental steps that impact form and function of the ciliated
organ of asymmetry. KV is derived from precursors called dorsal
forerunner cells (DFCs) (Cooper and D’Amico, 1996; Melby et al.,
1996; Oteiza et al., 2008) that migrate and proliferate during
epiboly stages of development and then cluster to differentiate
into the epithelial KV cells that form a ﬂuid-ﬁlled lumen during
early somite stages. Each KV cell assembles a single motile cilium
that projects into the lumen to generate asymmetric ﬂow. A large-
scale RNA in situ hybridization screen (Thisse and Thisse, 2004)
has identiﬁed genes with enriched expression in the DFC/KV cell
lineage, which provide entry points to uncover mechanisms that
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accessory protein of the vacuolar type Hþ-ATPase (V-ATPase) that
is similar to ATP6AP1, also known as Ac45 (Supek et al., 1994), in
other vertebrates. The V-ATPase is a multi-subunit proton pump
that localizes to membranes and uses ATP to move Hþ ions against
concentration gradients to acidify several intracellular compart-
ments, including secretory vesicles, endosomes and lysosomes.
The V-ATPase also associates with the plasma membrane in some
cell types to pump protons out of the cytoplasm into extracellular
space (Breton and Brown, 2013; Jefferies et al., 2008; Yang et al.,
2012). The 6-subunit membrane-bound Vo domain of the V-AT-
Pase transports protons and the 8-subunit V1 domain carries out
ATP hydrolysis. Several subunits have multiple isoforms that
control V-ATPase activity and subcellular localization (Breton and
Brown, 2013; Toei et al., 2010) and the accessory proteins Atp6ap1
and Atp6ap2 are also known to regulate V-ATPase functions in
speciﬁc cell types (Jansen and Martens, 2012). The expression of
zebraﬁsh Atp6ap1b in DFC/KV cells suggested this accessory pro-
tein modulates V-ATPase in these cells that are necessary for LR
development.
V-ATPase was previously identiﬁed as a regulator of LR pat-
terning in a screen of small molecule inhibitors in Xenopus
(Adams et al., 2006). Asymmetric activity of V-ATPase and
Hþ/Kþ-ATPase (Levin et al., 2002) in the early embryo has been
proposed to create an electrochemical gradient that localizes LR
determinants upstream of asymmetric Nodal expression. In zeb-
raﬁsh, pharmacological inhibition of V-ATPase from the 1-cell
stage to 3-somite stage resulted in fewer and shorter KV cilia and
disrupted LR patterning (Adams et al., 2006). Antisense depletion
of V-ATPase subunits also reduced KV cilia (Chen et al., 2012).
These studies have established that the V-ATPase is critical for cilia
development and LR asymmetry, but how the V-ATPase impacts
early steps of LR patterning in the embryo and how these V-AT-
Pase activities are regulated is not understood.
V-ATPases regulate pH homeostasis, protein degradation, ve-
sicle trafﬁcking and receptor-mediated endocytosis and function
in multiple signaling cascades (Forgac, 2007). V-ATPase accessory
proteins are known V-ATPase regulators, but roles for these pro-
teins during embryonic development are just starting to be elu-
cidated. Atp6ap1/Ac45 proteins are maternally supplied in Xeno-
pus (Jansen et al., 2010b; Rutenberg et al., 2002), zebraﬁsh
(Nuckels et al., 2009) and mouse (Schoonderwoert and Martens,
2002) embryos, suggesting functions during early vertebrate em-
bryogenesis. Mouse Atp6ap1 knockout embryonic stem cells do
not give rise to viable embryos, providing evidence for essential
role(s) in development (Qin et al., 2011; Schoonderwoert and
Martens, 2002). Zebraﬁsh homozygous atp6ap1ba82/a82mutant
embryos, in which a nonsense mutation truncates the Atp6ap1b
protein, appeared normal during the ﬁrst two days of develop-
ment until pigmentation defects distinguish them from wild-type
siblings (Nuckels et al., 2009). Loss of Atp6ap1b in zygotic mutant
embryos caused proliferation and apoptosis defects in the devel-
oping eye at 3–5 days of development, but earlier phenotypes
were not observed, likely due to maternal Atp6ap1b expression
(Nuckels et al., 2009).
Here, we use genetic and pharmacological approaches to in-
vestigate Atp6ap1b and V-ATPase functions during KV formation
and LR development in the zebraﬁsh embryo. Reducing both ma-
ternal and zygotic Atp6ap1b expression disrupted KV cilia forma-
tion and organ size and altered subsequent LR patterning. Loss of
Atp6ap1b also disrupted development of ciliated hair cells in
neuromasts. Analysis of precursor cells that give rise to KV in-
dicated Atp6ap1b functions as the ﬁrst known regulator of DFC
proliferation during epiboly stages to impact the LR development
pathway at timepoints that precede the appearance of cilia. Loss of
Atp6ap1b altered V-ATPase subcellular localizations and affectedcytoplasmic pH of DFCs. We propose a model in which Atp6ap1b
mediates V-ATPase proton ﬂux activity at the plasma membrane of
DFCs to maintain proliferation of these precursors that differ-
entiate into ciliated cells of the KV organ that are needed to es-
tablish the LR body plan.2. Results
2.1. Depletion of both maternal and zygotic Atp6ap1b disrupts
Kupffer’s vesicle organ size and function
RNA in situ hybridizations detected atp6ap1b mRNA at the
2-cell stage (Fig. 1A,B), which indicated it is maternally supplied
since the zygotic genome is not expressed during the ﬁrst 10
rounds of cell division. atp6ap1b mRNA was then enriched in DFCs
during epiboly stages (Fig. 1C,D) and in KV cells during early so-
mite stages (Fig. 1E) and observed in the brain, eye and mucus
secreting cells at 24 h post-fertilization (hpf) (Fig. 1F) as previously
described (Nuckels et al., 2009; Thisse and Thisse, 2004). RT-PCR
conﬁrmed maternal expression of atp6ap1b mRNA (Fig. S1A) and
ﬂuorescent immunostaining using antibodies raised against the
conserved C-terminus of human ATP6AP1 (Fig. S1B) detected
maternal protein (Fig. 1G–J). Interestingly, ATP6AP1 antibody sig-
nal appeared enriched at plasma membranes. In addition to at-
p6ap1b, the zebraﬁsh atp6ap1a gene is predicted to encode an-
other protein similar to human ATP6AP1 (Fig. S1B). atp6ap1a was
not expressed during the earliest stages of development and was
ﬁrst detected at 1 day post-fertilization (dpf) (Fig. S1A). RT-PCR
also indicated that V-ATPase Vo and V1 subunits are maternally
supplied and expressed during early development (Fig. S1C),
which is consistent with previous reports (Adams et al., 2006;
Chen et al., 2012; Nuckels et al., 2009). The prominent expression
of atp6ap1b in DFCs and the early KV made Atp6ap1b a strong
candidate as a regulator of KV development that may impact LR
asymmetry.
To determine whether loss of Atp6ap1b alters KV, we designed
antisense morpholino oligonucleotides (MO) to interfere with the
translation of both maternal and zygotic atp6ap1b mRNA.
Throughout this study, DFCs and KV cells were visualized in
transgenic Tg(sox17:GFP) embryos that express GFP in the DFC/KV
cell lineage (Sakaguchi et al., 2006) (Fig. 1K). ATP6AP1 antibodies
were used to assess Atp6ap1b expression levels and protein lo-
calization in MO injected embryos. In embryos injected with a
negative control MO, ATP6AP1 antibody staining at the 60% epi-
boly stage detected expression in the cytoplasm and at the plasma
membrane of sox17:GFP labeled DFCs as well as all other em-
bryonic cells (Fig. 1L–N), which is consistent with a global ma-
ternal supply of Atp6ap1b protein (Fig. 1H–J). The localization of
ATP6AP1 staining suggested Atp6ap1b may regulate V-ATPase
plasma membrane functions. Injecting atp6ap1b MO reduced AT-
P6AP1 antibody labeling (Fig. 1O–Q), indicating a marked, but not
complete, depletion of Atp6ap1b maternal and zygotic expression.
Western blots also indicated a partial and dose-dependent re-
duction of ATP6AP1 in MO injected embryos (Fig. 1R). ATP6AP1
antibodies detected a prominent band just below 50 kDa—con-
sistent with Atp6ap1/Ac45 proteins (40–45 kDa) in other ver-
tebrates—that was reduced in atp6ap1b MO and atpap1ba82/a82
mutant embryos. The antibody also recognized a band above
50 kDa that was diminished in atp6ap1b MO embryo extracts
collected during early somite stages, but was not present in wild-
type extracts at 7 dpf (Fig. 1R). Work in Xenopus has shown that
intact Atp6ap1/Ac45 is a 62 kDa glycosylated protein that is pro-
cessed into 40 kDa cleaved protein (Holthuis et al., 1999;
Schoonderwoert et al., 2002), which suggests the higher band
present in early zebraﬁsh extracts represents the intact
Fig. 1. Atp6ap1b is maternally supplied and prominently expressed in dorsal forerunner cells and Kupffer’s vesicle. (A–F) RNA in situ hybridizations of atp6ap1b during early
zebraﬁsh development. (A) Antisense atp6ap1b probes revealed maternal atp6ap1bmRNA in the 2-cell embryo. (B) A control atp6ap1b sense probe showed no staining. (C–E)
atp6ap1b mRNA was detected in DFCs and KV cells during epiboly and early somite stages. (F) atp6ap1b was observed in mucus secreting cells, eye and brain at 24 hpf. (G–J)
Fluorescent immunostaining with ATP6AP1 antibodies detected maternal protein at the 2-cell (H), 64-cell (I) and 128-cell (J) stages. There was no signal in control ex-
periments that lacked ATP6AP1 antibody (G). (K) Schematic diagram and whole-embryo view of a Tg(sox17:GFP) embryo that expresses GFP in DFCs and endoderm at 80%
epiboly. The box indicates the approximate region of interest shown in L–Q. (L–Q) ATP6AP1 antibodies labeled all cells during epiboly stages, including GFPþ DFCs, in control
MO injected Tg(sox17:GFP) embryos (L–N). Jup antibodies were used to mark plasma membranes in DFCs. Insets show ATP6AP1 staining was observed in the cytoplasm and
plasma membranes. ATP6AP1 staining was reduced in Atp6ap1b MO embryos (O–Q). (R) Western blot analysis of Atp6ap1 expression. ATP6AP1 antibodies detected pro-
minent bands just under 50 kDa (arrowhead) and just higher that 50 kDa (arrow) in control embryos at the bud stage (10 hpf) that were reduced in a dose-dependent
fashion in atp6ap1b MO embryos. The lower band was detected in wild-type embryos at 7 dpf, and was reduced in atp6ap1ba82/a82 mutants. Tubulin was used as a loading
control. The graph shows average relative intensities of both Atp6ap1 bands from three MO experiments.
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tion in Atp6ap1b expression in the early embryo had an impact on
KV development, embryos were analyzed at the 8 somite stage (13
hpf) when asymmetric ﬂuid ﬂow is active in KV. Tg(sox17:GFP)
embryos injected with atp6ap1b MO appeared similar to controls
and formed a KV consisting of GFP labeled cells (Fig. 2A,B). How-
ever, KV was consistently smaller in atp6ap1b MO embryos
(Fig. 2B) as compared to controls (Fig. 2A). Antibodies that detect
atypical protein kinase C (aPKC) or acetylated tubulin (ac-Tub)
were used to label apical membranes of KV cells and KV cilia, re-
spectively (Fig. 2C,D). Quantiﬁcation of KV area, as deﬁned by aPKC
labeling, revealed a statistically signiﬁcant reduction of KV organ
size in atp6ap1b MO embryos (Fig. 2E). In addition, both the
number and length of KV cilia were reduced in Atp6ap1b depleted
embryos relative to controls (Fig. 2F,G). To test the speciﬁcity of KV
defects in MO embryos, we performed rescue experiments using
full-length atp6ap1b mRNA. Co-injection of 2 ng of atp6ap1b MO
with 50 pg MO-resistant atp6ap1b mRNA resulted in signiﬁcant
rescue of KV size, cilia number and cilia length, indicating KV
phenotypes are speciﬁc to Atp6ap1b knockdown (Fig. 2E–G).
These results revealed Atp6ap1b function is critical for KV cilia
development and establishing proper KV organ size.
To determine whether phenotypes observed in atp6ap1b MO
embryos were also seen in zygotic atp6ap1ba82/a82 mutants thatappear normal up to 2 dpf, we analyzed ciliated organs—neuro-
masts in the lateral line system—at 3 dpf. Neuromasts contain hair
cells that assemble long microtubule-based kinocilia surrounded
by several short actin-based stereocilia (Ghysen and Dambly-
Chaudiere, 2007). Reminiscent of KV defects, we found reduced
kinocilia length and neuromast size in atp6ap1b MO embryos at
3 dpf (Fig. 2H–K). Analysis of neuromasts in atp6ap1ba82/a82 mu-
tants, identiﬁed by reduced pigmentation (Fig. S1D), also showed
kinocilia and size defects at 3 dpf (Fig. 2K–M). Western blotting
and immunostaining indicated ATP6AP1 levels were only slightly
reduced in mutants relative to wild-type siblings at 3 dpf, but were
then more signiﬁcantly reduced at 5 and 7 dpf (Fig. S1E–F). The
source of the remaining ATP6AP1 signal was not clear, but could be
due to residual maternal Atp6ap1b and/or cross-reactivity with
Atp6ap1a protein. Consistent with the reduction of ATP6AP1 signal
over time, quantiﬁcation of kinocilia length in atp6ap1ba82/a82
mutant embryos at 3, 5 and 7 dpf revealed cilia phenotypes wor-
sened during development (Fig. S2A,B). Similarly, we observed
defects in the formation of the ciliated epithelium in the olfactory
placode (Malicki, 2012) in atp6ap1ba82/a82 embryos as compared to
wild-type siblings (Fig. S2C). Overall, these complementary results
using MO and mutant embryos suggest a role for Atp6ap1b in
development of ciliated organs.
Consistent with defects in KV organ formation, atp6ap1b MO
Fig. 2. Atp6ap1b depletion altered KV organ size and cilia formation. (A, B) Analysis of live Tg(sox17:GFP) embryos injected with control (A) or atp6ap1b MO (B) at the
8 somite stage. atp6ap1b MO embryos were indistinguishable from controls except for the small size of KV (arrows) labeled by GFP expression. The notochord (arrowheads)
appeared normal in atp6ap1b MO embryos. (C, D) Immunoﬂuorescent staining of KVs using aPKC antibodies to label apical membranes and acetylated tubulin (ac-Tub)
antibodies to label cilia in control (C) or atp6ap1b (D) MO embryos. (E–G) Quantiﬁcation of KV area (E), KV cilia number (F), and KV cilia length (G) in control MO (n¼32)
embryos, atp6ap1b MO injected (n¼53) embryos and rescue (n¼34) embryos co-injected with atp6ap1b MOþatp6ap1b mRNA. (H-M) Analysis of neuromasts stained with
ac-Tub antibodies at 3 dpf in control MO and atp6ap1b MO embryos (H) or wild-type and atp6ap1ba82/a82 mutants (K). Kinocilia cluster length and neuromast area were
reduced in atp6ap1b MO injected (n¼13) embryos relative to controls (n¼13) (I–J) and in atp6ap1ba82/a82 mutants (n¼7) relative to wild-type (n¼7) siblings (L–M). All scale
bars¼5 μm.
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Fig. 3. Depletion of maternal and zygotic Atp6ap1b disrupted LR patterning. (A–C) RNA in situ hybridizations of the cardiac-speciﬁc cmlc2 marker were used to assess heart
looping (arrow) at 2 dpf. v¼ventricle; a¼atrium. Normal rightward looping (A) was observed in wild-type embryos, whereas heart looping often failed (B) or was reversed
(C) in embryos injected with two different translation-blocking MOs. (D) Quantiﬁcation of heart looping phenotypes in atp6ap1b MO embryos. MO-induced heart looping
defects were partially rescued by co-injection with atp6ap1b mRNA. (E–H) RNA in situ hybridization analysis of spaw expression (arrow) at 18 somite stage that is left-sided
in controls (E), but reversed (F), bilateral (G) or absent (H) in many atp6ap1b MO embryos (I).
J.J. Gokey et al. / Developmental Biology 407 (2015) 115–130 119embryos developed LR patterning defects. In contrast to normal
rightward looping of the heart tube in wild-type embryos at 2 dpf
(Fig. 3A), the heart often failed to loop or looped in the reversed
direction in embryos injected with two independent translation-blocking MOs (Fig. 3B–D). LR defects in atp6ap1b MO embryos
were further characterized by analyzing asymmetric Nodal sig-
naling that preceded heart looping. Normal left-sided expression
of Nodal-related gene southpaw (spaw) observed in controls at the
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sent in Atp6ap1b depleted embryos (Fig. 3F–I). This indicated
speciﬁcation of the LR axis was disrupted. Importantly, midline
structures, such as the notochord, which restrict Nodal signaling to
the left side, remained intact in atp6ap1b MO embryos. Im-
portantly, atp6ap1b MO defects in heart looping (Fig. 3D) and
spaw expression (Fig. 3I) were signiﬁcantly rescued by MO-re-
sistant atp6ap1b mRNA. Mutant atp6ap1ba82/a82 embryos were
indistinguishable from wild-type siblings during KV development
stages and did not have defects in KV size (Fig. S3A) or cardiac
looping (Fig. S3B). The overall normal development of
atp6ap1ba82/a82 mutants during the ﬁrst 2 dpf suggested maternal
atp6ap1b expression is sufﬁcient for early development.Fig. 4. Inhibiting V-ATPase function disrupted cardiac left–right asymmetry, KV organ si
stage and the 6 somite stage or MO depletion of Atp6v1f altered heart looping as compa
atp6v1f mRNA. (B–D) Immunoﬂuorescent staining of KV using aPKC and acetylated-Tubu
(G) in DMSO control (n¼17) embryos, concanamycin A treated (n¼26) embryos and at2.2. Interfering with V-ATPase activity phenocopies Atp6ap1b
depletion
V-ATPase accessory proteins are known to regulate V-ATPase
activity (Jansen et al., 2010a, 2008, 2012), but these proteins could
also have V-ATPase-independent functions. We took two ap-
proaches to test whether KV phenotypes in Atp6ap1b depleted
embryos are linked to altered V-ATPase function. We ﬁrst treated
embryos with the small molecule Concanamycin A that inhibits
V-ATPase activity (Manabe et al., 1993; Nishihara et al., 1995).
Embryos treated with 175 nM Concanamycin A in 1% DMSO from
the 50% epiboly stage to the 6 somite stage showed heart looping
defects that were not seen in control embryos treated with 1%ze and KV cilia formation. (A) Concanamycin A treatments between the 50% epiboly
red to controls. Heart defects in atp6v1f MO embryos were signiﬁcantly rescued by
lin markers. (E–G) Quantiﬁcation of KV cilia length (E), cilia number (F), and KV size
p6v1f MO injected (n¼22) embryos. Scale bars¼5 μm.
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showed shorter and fewer KV cilia (Fig. 4B,C,E,F), which is con-
sistent with previous perturbations of V-ATPase (Adams et al.,
2006; Chen et al., 2012). In addition, analysis of KV organ size
revealed that Concanamycin A treatments resulted in a sig-
niﬁcantly smaller KV (Fig. 4G). This suggested interfering with
V-ATPase activity during KV development stages results in similar
phenotypes observed in Atp6ap1b depleted embryos.
As a second approach to test the requirement of V-ATPase ac-
tivity during KV development, we designed a MO to block trans-
lation of atp6v1f mRNA that encodes the V1F subunit. Loss of V1F
prevents V-ATPase assembly and function (Graham et al., 2000).
Embryos injected with atp6v1f MO displayed heart lateralityFig. 5. V-ATPase activity during epiboly stages is necessary for LR asymmetry. (A) Timeli
treatment windows and a summary of results. (C) Heart looping phenotypes at 2 dpf in
concanamycin A treated embryos at the indicated developmental stages.defects (Fig. 4A) similar to atp6ap1b MO and concanamycin A
treated embryos. LR asymmetry of the heart was signiﬁcantly
rescued in atp6v1f MO embryos co-injected with MO-resistant
atp6v1f mRNA (Fig. 4A). We next tested whether atp6ap1b and
atp6v1f genetically interact to regulate cardiac LR asymmetry by
co-injecting low doses of atp6ap1b MOþatp6v1f MO. This co-in-
jection resulted in a higher incidence of LR defects than injecting
each MO individually (Fig. S4), suggesting Atp6ap1b and Atp6v1f
MO function in the same pathway to affect heart asymmetry.
Analyses of KV organogenesis revealed that KV size and cilia were
signiﬁcantly reduced in atp6v1f MO embryos (Fig. 4D–G). Taken
together, the similar phenotypes observed in atp6ap1b MO em-
bryos, atp6v1f MO embryos and concanamycin A treated embryosne of zebraﬁsh developmental events critical for LR patterning. (B) Concanamycin A
DMSO control embryos (treated between 50% epiboly and the 6 somite stage) and
Fig. 6. Atp6ap1b depletion reduced cytoplasmic pH of DFCs. (A–F) Analysis of cytoplasmic pH in living embryos during epiboly stages using SNARF-5F ﬂuorescent indicator.
DFCs (A,D) are labeled with GFP in Tg(sox17:GFP) embryos and are outlined with a dotted line. (B,E) pH-dependent SNARF-5F ﬂuorescence at 640 nm. (C,F) Pseudocolored
ratiometric (640 nm/580 nm) image of SNARF-5F signals. Blue indicates high pH and red indicates low pH. (G–L) LysoTracker vital dye labeling of acidic compartments (e.g.
lysosomes) in live embryos. (G,J) GFPþ DFCs are outlined with a dotted line. (H,K) LysoTracker ﬂuorescent staining labels acidic organelles. (I,L) Merged overlay of Lysot-
Tracker (red) and DFCs (green). (M) Quantiﬁcation of SNARF-5F ratio in DFCs and adjacent dorsal margin cells in control MO and atp6ap1 MO injected embryos.
(N) Quantiﬁcation of LysoTracker ﬂuorescence in control and atp6ap1 MO embryos. ns¼not signiﬁcant. AU¼ arbitrary units.
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Fig. 7. Atp6v1a localization in DFCs is altered in Atp6ap1b depleted embryos. (A,B)
Confocal sections through a subset of DFCs labeled with Atp6v1a antibodies.
Punctate Atp6v1a signals were detected in the cytoplasm and along some plasma
membranes (arrows) marked by Jup antibodies in DFCs in Tg(sox17:GFP) embryos
injected with control MO (A). A′ and A″ show enlarged images of the boxed regions
in A. Plasma membrane association of Atpv1a signals was reduced in Atp6ap1b MO
embryos (B). B′ and B″ show enlarged images of the boxed regions in B. (C) A
plasma membrane-to-cytoplasm ratio of Atp6v1a ﬂuorescence in DFCs. (D) Overall
Atpv1a ﬂuorescence in DFCs. (E) The percentage of DFCs found to have Atp6v1a
puncta associated with Jup staining at the plasma membrane.
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velopment and LR axis determination.
2.3. V-ATPase activity is required during epiboly stages for normal
left–right asymmetry
To gain insight into V-ATPase functions we used concanamycin
A treatments to identify a window of development where V-AT-
Pase activity is needed for normal LR asymmetry. Our initial
treatments between 50% epiboly stage and the 6 somite stage
(Fig. 4) encompassed several steps of DFC/KV development
(Fig. 5A), including DFC speciﬁcation, migration, proliferation, KV
morphogenesis, and cilia formation. We used several treatment
periods (Fig. 5B) to determine which step(s) depend on V-ATPase
activity. Embryos placed in 175 nM concanamycin A at the 50% or
60% epiboly stage and then removed at the 75% epiboly stage
showed signiﬁcant heart LR defects at 2 dpf (Fig. 5C). Importantly,
we determined that this dose of concanamycin A effectively blocks
V-ATPase activity in the DFCs within 30 min (Fig. S5). Treatments
between the 75% epiboly stage and the bud stage also altered heart
looping (Fig. 5C), but at a lower frequency. In contrast, treating
embryos between 90% epiboly and the 3 somite stage or between
the bud stage and the 6 somite stage did not have a signiﬁcant
effect on heart asymmetry (Fig. 5C). Collectively, these results have
identiﬁed a developmental window during epiboly stages (50%
epiboly-bud stage) that requires V-ATPase for normal LR
asymmetry.
2.4. Depletion of Atp6ap1b changes the cytoplasmic pH of dorsal
forerunner cells
The ﬁnding that V-ATPase activity during epiboly stages is cri-
tical for normal LR development led us to focus on DFCs. Since
V-ATPase is known to regulate pH of cell organelles and/or cyto-
plasm, we used vital dyes to analyze pH in living embryos. Cyto-
plasmic pH in DFCs was visualized by placing embryos in the cell
permeable ratiometric pH indicator dye SNARF-5F that undergoes a
pH-dependent emission shift that can determine relative pH values
in cultured cells (Buckler and Vaughan-Jones, 1990; Morley et al.,
1996), chick embryos (Adams et al., 2006) and zebraﬁsh embryos
(Fig. S6). In control MO injected Tg(sox17:GFP) embryos, SNARF-5F
640/580 nm ratiometric signals were similar in GFPþ DFCs and
surrounding dorsal margin cells (Fig. 6A–C,M), indicating a rela-
tively uniform pH. In contrast, depletion of Atp6ap1b consistently
reduced SNARF-5F ratiometric signal in all cells and resulted in a
striking reduction in DFCs relative to neighboring cells (Fig. 6D–F,
M). These observations indicate that reducing both maternal and
zygotic expression of Atp6ap1b acidiﬁes the cytoplasm moderately
in dorsal margin cells and more dramatically in DFCs, such that the
pH of DFCs is quite different than adjacent cells. Since V-ATPase is
also critical for the acidiﬁcation of organelles such as lysosomes, we
used the ﬂuorescent dye LysoTracker to label acidic cellular com-
partments in live embryos. Fluorescent LysoTracker signals were
present in Atp6ap1b MO embryos and appeared similar to controls
suggesting no signiﬁcant change in the number of acidic lysosomes
(Fig. 6G–L,N). Together, these results indicate Atp6ap1b is important
for maintaining cytoplasmic pH of DFCs.
2.5. Loss of Atp6ap1b alters V-ATPase subcellular localization
To begin to understand how Atp6ap1b modulates V-ATPase
activity in vivo, we tested whether loss of Atp6ap1b altered
V-ATPase subcellular localization. Since Atp6ap1b is enriched at
plasma membranes during early development (Fig. 1M), we hy-
pothesized Atp6ap1b may recruit the V-ATPase to the plasma
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the V1A subunit (Atp6v1a) that have been validated in zebraﬁsh
(Einhorn et al., 2012). Whole-mount immunostaining experiments
to detect Atp6v1a in KV cells at 8 somite stage were unsuccessful,
potentially due to the inability of the antibodies to penetrate into
deep tissues. Analysis of DFCs in control embryos at the 70–80%
epiboly stage, when these cells are closer to the surface of the
embryo, revealed punctate Atp6v1a staining throughout the cy-
toplasm and some puncta were observed along plasma mem-
branes that were marked with the cell-cell adhesion molecule
Junction plakoglobin (Jup) (Martin et al., 2009) (Fig. 7A,A′,A″). This
staining pattern was reminiscent of V-ATPase V1A localization at
the plasma membrane in Xenopus melanotrope cells expressing a
GFP-tagged Ac45/Atp6ap1 transgene (Jansen et al., 2008). A ratio
of plasma membrane-to-cytoplasm ﬂuorescence in DFCs revealed
a modest enrichment of Atp6v1a on the plasma membrane in
control embryos that was reduced in Atp6ap1b MO embryos
(Fig. 7B,C), whereas the overall mean ﬂuorescent intensity of
Atp6v1a staining in DFCs was similar (Fig. 7D). Interestingly, not all
plasma membranes stained positive for Atp6v1a. However, ana-
lysis of Z-sections of confocal images revealed that the majority of
DFCs in control embryos had Atp6v1a puncta associated with Jup
labeled membranes, and that this association was greatly reduced
in Atp6ap1b MO embryos (Fig. 7E). To test speciﬁcity of the anti-
body signal, we used a second commercial Atp6v1a antibody and
found a similar distribution of punctate staining along some
plasma membranes in control DFCs that was reduced in Atp6ap1b
MO DFCs (Fig. S7). These results indicate a role for Atp6ap1b in
V-ATPase localization at DFC plasma membranes. Mislocalization
of the V-ATPase in these cells is consistent with increased acid-
iﬁcation of the cytoplasm observed using SNARF-5F.
To test whether loss of Atp6ap1b altered V-ATPase localization
in other cell types, we analyzed enveloping layer (EVL) cells that
lie on the surface of the embryo during epiboly stages and hair
cells in neuromasts. Similar to DFCs, Atp6v1a puncta were found in
EVL cells throughout the cytoplasm and at some plasma mem-
branes in controls, whereas Atp6ap1b depletion reduced plasma
membrane enrichment (Fig. S8). In neuromasts, previous work has
shown that V-ATPase is enriched at the basal side of hair cells
(Einhorn et al., 2012). Analysis of the basal-to-apical ratio of
Atp6v1a in hair cells at 3 dpf revealed a signiﬁcant difference in
distribution between wild-type and atp6ap1ba82/a82mutant em-
bryos (Fig. S8). Taken together, our analyses of MO and mutants
indicate Atp6ap1b modulates the subcellular localization of
V-ATPase in vivo, which suggests a plausible mechanism for how
Atp6ap1b regulates activity of the V-ATPase enzyme.
2.6. Atp6ap1b depletion reduces the number of dorsal forerunner
cells that give rise to Kupffer’s vesicle
Since KV size and KV cilia number were both reduced in at-
p6ap1b MO embryos, we asked whether fewer DFCs incorporated
into these KVs. Using Tg(sox17:GFP) embryos, we found a sig-Fig. 8. Atp6ap1b regulates proliferation of DFCs. (A–C) Quantiﬁcation of DFC/KV
cell numbers in Tg(sox17:GFP) embryos between 60% epiboly and 8 somite stages
revealed a reduction of cells in atp6ap1b MO injected embryos relative to con-
trols. (D–I) Phosphorylated Histone H3 (pHH3) antibodies labeled proliferating
cells in Tg(sox17:GFP) embryos injected with control MO (D–F) or atp6ap1b MO
(G–I). Merged images (F,I) of DFCs (green) and pHH3 (red) show examples of
proliferating DFCs (arrows) at the 60% epiboly stage. (J) Percentage of embryos
with proliferating DFCs at the indicated stages. (K) The percentage of DFCs pro-
liferating in control MO and Atp6ap1 MO injected embryos. (L–M) Embryos in-
jected with atp6v1f MO or treated with concanamycin A between the 50% and
75% epiboly stages were analyzed at the 80% epiboly stage. Treated embryos had a
reduced number of DFCs (L) and reduced DFC proliferation (M) as compared to
controls. (N) In contrast to DFCs, there was no difference in pHH3 labeling of
neighboring dorsal margin cells between atp6ap1b MO and control embryos.niﬁcant decrease in the average number of GFPþ KV cells in the
atp6ap1 MO embryos at the 8 somite stage as compared to con-
trols (Fig. 8A–C). This indicated the incorporation of fewer cells
contributed to the reduced KV organ size in atp6ap1 MO embryos.
In addition, the average number of KV cells in atp6ap1b depleted
embryos (31þ6 cells) was similar to the average number of KV
cilia (30710 cilla; see Fig. 2H) in these embryos, suggesting the
decrease in cilia number is due to the reduced number of KV cells.
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during epiboly stages to explore whether the reduction of KV cells
in atp6ap1b MO injected embryos reﬂected a defect in the DFC
precursor population. At the 60% epiboly stage, the number of
DFCs was similar in control and atp6ap1b MO embryos (Fig. 8C),
indicating the speciﬁcation of DFCs was not affected by loss of
Atp6ap1b. However, at later stages of epiboly there were fewer
DFCs in Atp6ap1b depleted embryos relative to controls (Fig. 8C).
In wild-type embryos, the number of DFCs steadily increased be-
tween 60% epiboly and the bud stage and then plateaued. In At-
p6ap1b depleted embryos, the number of DFCs also increased, but
at a slower rate resulting in fewer cells at KV stages. These results
indicated Atp6ap1b functions during epiboly stages to regulate the
number of DFCs.
2.7. Atp6ap1b is required to maintain DFC proliferation rate
The reduced number of DFCs observed in atp6ap1b MO em-
bryos could result from several different mechanisms, including a
defect in DFC movements, an increase in DFC cell death, or a de-
crease in DFC proliferation. Time-lapse imaging of GFPþ DFCs in
live Tg(sox17:GFP) embryos between 60% and 90% epiboly stages
revealed DFC migration dynamics in atp6ap1b MO embryos were
similar to controls (Fig. S9; Movies1, 2). This indicated the reduc-
tion of DFCs was not due to migration defects or a failure of DFCs
to coalesce during epiboly. RNA in situ hybridizations of en-
dogenous sox17 expression conﬁrmed that DFCs were similarly
clustered in both control (n¼32/32 embryos) and atp6ap1b MO
(n¼35/36) embryos at the 80% epiboly stage. We next asked
whether DFCs were undergoing increased apoptosis in Atp6ap1b
depleted embryos. Annexin V labeling was used to identify
apoptotic cells in Tg(sox17:GFP) embryos (Fig. S10A–C). No Annexin
V labeled DFCs were detected in control MO (n¼13) or Atp6ap1b
MO (n¼12) embryos between 60% epiboly and bud stage. Con-
sistent with this ﬁnding, co-injecting atp6ap1b MO with p53 MO
that inhibits p53-dependent apoptosis (Robu et al., 2007) reduced
KV size and cilia number (Fig. S10D–E), just as observed in em-
bryos injected with atp6ap1b MO alone (Fig. 2E–F). Together, these
results indicated the reduction of the DFC pool in Atp6ap1b de-
pleted embryos is not due to cell movement defects or increased
apoptosis.
Supplementary material related to this article can be found
online at
To test whether depletion of Atp6ap1b altered proliferation of
DFCs, we quantiﬁed the number of proliferating DFCs throughout
epiboly stages using phosphorylated Histone H3 (PHH3) anti-
bodies as a mitotic marker in Tg(sox17:GFP) embryos (Fig. 8D–I).
Nearly all control embryos contained proliferating DFCs (at least
one PHH3þ DFC) and we observed the highest rates of prolifera-
tion during epiboly, which then sharply declined at the bud stage
when DFCs begin to differentiate into epithelial KV cells (Fig. 8J,K).
In contrast to controls, the percentage of Atp6ap1b depleted em-
bryos containing PHH3 labeled DFCs was greatly reduced and the
percentage of PHH3þ DFCs in atp6ap1b MO embryos was low
throughout epiboly (Fig. 8J,K). This analysis identiﬁed a defect in
DFC proliferation in Atp6ap1b depleted embryos and indicated a
reduced proliferation rate of DFCs as an underlying cause of KV
organ size defects in these embryos. To conﬁrm these results, we
treated embryos with either concanamycin A between the 50-75%
epiboly stages or atp6v1f MO doses that disrupted LR patterning.
Similar to Atp6ap1b depleted embryos, concanamycin A treated
and atp6v1f MO injected embryos had fewer DFCs and a reduced
percentage of PHH3þ DFCs relative to controls (Fig. 8L–M). Finally,
to determine whether proliferation defects were global or speciﬁc
to DFCs during epiboly, we quantiﬁed PHH3 staining in a group of
dorsal margin cells that was equivalent to the size of the DFCcluster. This showed that unlike DFCs, there was no difference in
proliferation of neighboring cells in atp6ap1b MO embryos when
compared to controls (Fig. 8N). Together, these results support a
model in which Atp6ap1b-regulated V-ATPase activity mediates
proliferation of DFCs that is necessary to build a functional KV
organ that can effectively propagate LR signaling in the embryo.3. Discussion
Asymmetric patterns of gene expression that deﬁne the left and
right sides of the embryo are well documented, but upstream
mechanisms that ensure correct LR patterning are poorly under-
stood. In this study, we identiﬁed functions of the V-ATPase and its
accessory protein Atp6ap1b in regulating development of the
zebraﬁsh ciliated organ of asymmetry that plays a central role in
LR signaling. Using brief treatments with a small molecule in-
hibitor of the V-ATPase, we found a speciﬁc window of develop-
ment that requires V-ATPase activity to establish normal LR
asymmetry. This tight window during gastrulation stages corres-
ponds to the development of precursor cells (DFCs) that give rise
to the organ of asymmetry (KV). Consistent with this ﬁnding, de-
pleting maternal and zygotic Atp6ap1b or blocking V-ATPase ac-
tivity in the early embryo reduced the proliferation and overall
population of DFCs. The decrease in the pool of DFCs subsequently
results in fewer KV cells, which provides an explanation for the
smaller KV organ size observed in embryos treated with inhibitors
of the V-ATPase. Our results uncover an important new function
for the V-ATPase accessory protein Atp6ap1b in modulating the
number of ciliated cells in the organ of asymmetry.
It is important to note that KV development and LR patterning
defects were not observed in zygotic loss-of-function atp6ap1b
mutant zebraﬁsh, which complete the ﬁrst two days of develop-
ment without gross phenotypes. Although atp6ap1b is expressed
in speciﬁc cell types (e.g. DFC/KV cells) during early development
(Fig. 1), maternally supplied mRNAs appear to compensate for
early functions and mask phenotypes in zygotic mutants. To
identify Atp6ap1b functions, we used complementary analyses of
zygotic mutants and embryos injected with translation-blocking
MOs that reduce both maternal and zygotic atp6ap1b expression.
MO depletions and rescue experiments revealed defects in KV
development, which is consistent with the expression of atp6ap1b
in KV cells. Analysis of ciliated neuromasts in atp6ap1b MO em-
bryos and zygotic atp6ap1b mutants during later development—
when maternal atp6ap1b is depleted—revealed similar defects in
kinocilia and neuromast size. Defects in the development of the
ciliated olfactory placode development were also observed in at-
p6ap1b mutants. Together, these analyses indicate atp6ap1b reg-
ulates KV and neuromast development and suggest a broader role
for Atp6ap1b in the formation of ciliated organs. This approach has
successfully uncovered Atp6ap1b functions during early embry-
ogenesis that were missed in zygotic mutants.
3.1. V-ATPase and its accessory proteins in development
V-ATPase activity has been implicated in regulating several cell
behaviors that are key to embryo development, including differ-
entiation, migration, survival and proliferation (Hernandez et al.,
2012; Nuckels et al., 2009; Tuttle et al., 2014). Little is known about
the roles of V-ATPase accessory proteins in development, but it is
plausible that these factors modulate speciﬁc V-ATPase functions
in speciﬁc cell types. To date, the functions of Atp6ap1 in devel-
opment have not been analyzed in mouse because knockout em-
bryonic stem cells do not give rise to viable embryos (Schoon-
derwoert and Martens, 2002). In zebraﬁsh, mutations in Atp6ap1b
or Atp6ap2 result in overlapping phenotypes that include
Fig. 9. Working model for how Atp6ap1b regulates V-ATPase activity and LR pat-
terning. We propose Atp6ap1b mediates localization of the V-ATPase to the plasma
membrane in DFCs to control ion ﬂux and cytoplasmic pH that impacts DFC pro-
liferation rates and KV organ size. It is not yet clear whether V-ATPase activity
regulates cilia length via ion ﬂux/pH control or independent mechanisms.
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(EauClaire et al., 2012; Nuckels et al., 2009). atp6ap1b mutants
showed reduced proliferation of retinoblasts, altered cell cycle exit
in these cells and increased apoptosis of neurons (Nuckels et al.,
2009). These phenotypes were also present in embryos with
mutations in V-ATPase subunits, providing additional evidence
that Atp6ap1b modulates V-ATPase functions during development.
The phenotypic difference between mouse Atp6ap1/Ac45 mutants
and zebraﬁsh atp6ap1b mutants is likely due, at least in part, to a
stable maternal supply of Atp6ap1b protein in the zebraﬁsh em-
bryo. However, it is also possible that expression of atp6ap1a, a
second zebraﬁsh gene that is similar to Atp6ap1/Ac45, may com-
pensate for some Atp6ap1b functions. We show that reducing both
maternal and zygotic expression of Atp6ap1b is sufﬁcient to un-
cover early developmental phenotypes, which included decreased
DFC proliferation. A role for Atp6ap1b in regulating proliferation is
consistent with observations in the atp6ap1b mutant eye (Nuckels
et al., 2009), suggesting Atp6ap1b may regulate proliferation in
multiple cell types during development.
Studies in Xenopus suggest V-ATPase activity establishes an
asymmetric Hþ ﬂux at the 4–8 cells stages that creates asym-
metric membrane potential at the 16-cell stage that is critical for
cilia formation and LR patterning (Adams et al., 2006). Manip-
ulation of embryo pH or membrane potential altered LR pattern-
ing, underscoring the importance of Hþ ﬂux in this process. Ge-
netic approaches have conﬁrmed a role for V-ATPase in cilia de-
velopment: we observed cilia defects in Atp6v1f depleted embryos
(Fig. 4) and MO depletion of the Vod1 subunit was previously
shown to reduce cilia formation in KV and neuromasts (Chen et al.,
2012). In mammalian cell cultures, the V1D subunit was found to
interact with Sorting nexin 10 (SNX10) and V-ATPase activity was
implicated in vesicle trafﬁcking necessary for ciliogenesis (e.g. the
initiation of cilia formation) (Chen et al., 2012). We show loss of
Atp6ap1b also results in reduced cilia number and length, in-
dicating this accessory protein is critical for V-ATPase activity
during cilia development. However, in contrast to a defect in ci-
liogenesis, we found that a reduced number of KV cilia in At-
p6ap1b depleted embryos correlated with a reduced number of KV
cells. We therefore conclude that Atp6ap1b function regulates cilia
length, but is not required for ciliogenesis in KV.
The functions of the V-ATPase during early steps of LR pat-
terning and how these functions are regulated are not fully un-
derstood. Our results in zebraﬁsh indicate the accessory protein
Atp6ap1b modulates the V-ATPase during KV organ development
to regulate proliferation of the precursor DFC population and the
length of KV cilia. We speculate that LR asymmetry defects caused
by interfering with the V-ATPase are due to the combination of
both a reduced number of KV cilia and the shorter length of these
cilia that generate ﬂuid ﬂows necessary for proper LR patterning
(Fig. 9). Insufﬁcient ﬂows in KV due to fewer and shorter cilia
would be consistent with the spaw and heart laterality defects
seen in atp6ap1 MO embryos. Shortened KV cilia in atp6ap1 MO
embryos were still motile, but it is likely that ﬂuid ﬂow dynamics
were signiﬁcantly altered in these embryos. Our attempts to ana-
lyze ﬂow dynamics by injecting ﬂuorescent beads into KV (Wang
et al., 2013) were not successful due to the small KV size in at-
p6ap1b MO embryos. It also remains possible that the reduction of
KV size and/or fewer KV cells may dramatically change the cellular
topography inside KV that may be important for ﬂow generation
and/or detection. Additional work is needed to better understand
the role of KV architecture and KV size in LR axis determination.
3.2. Atp6ap1b, proliferation and cilia length
A group of 20–25 DFCs at the 50% epiboly stage proliferate to
give rise to 50 epithelial cells that assemble cilia in the matureKV organ. The number of KV cells can be variable among wild-type
embryos, but the nature of this variation remains unclear. Previous
studies have identiﬁed roles for Syndecan 2 (Arrington et al.,
2013), and β-catenin, (Zhang et al., 2012), in DFC/KV cell pro-
liferation during somite stages, but regulators of DFC proliferation
during epiboly have not been identiﬁed. A roadblock to under-
standing DFC/KV cell proliferation has been the lack of a com-
prehensive census of the DFC/KV cell population during their de-
velopment. We report for the ﬁrst time an average number of DFCs
present at several stages of development and a proliferation proﬁle
of DFCs during epiboly (Fig. 8). In control embryos, most pro-
liferation occurred between 60% and 70% epiboly and then de-
clined towards the end of epiboly when DFCs exit the cell cycle to
differentiate into ciliated epithelial KV cells. Depletion of Atp6ap1b
reduced—but did not abolish—DFC proliferation throughout epi-
boly stages, suggesting a role in maintaining proliferation rate.
These results identify Atp6ap1b as the ﬁrst regulatory factor of
DFC proliferation during epiboly stages.
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expression of Xenopus Ac45/Atp6ap1 in melanotrope cells in-
creased the plasma membrane localization of the V-ATPase (Jan-
sen et al., 2008). Reminiscent of these results, we found zebraﬁsh
Atp6ap1b associates with plasma membranes in DFCs and we
detected a reduction of V-ATPase subunit Atp6v1a at plasma
membranes in Atp6ap1b depleted embryos. It is not clear why we
detected Atp6v1a at only some plasma membranes in DFCs (Fig. 7)
and EVL cells (Fig. S8). This could be due to antibody variabilities
or may reﬂect a potentially interesting distribution of the V-AT-
Pase in a subset of cells or at speciﬁc membrane locations within a
given cell. Mislocalization of V-ATPase away from the plasma
membrane is consistent with the accumulation of protons (lower
pH) in the cytoplasm that was observed in Atp6ap1b depleted
DFCs using SNARF-5F. We propose a model in which Atp6ap1b
functions to mediate localization of the V-ATPase to the plasma
membrane in DFCs where it pumps protons out of the cell, such
that loss of Atp6ap1b alters proton ﬂux in DFCs (Fig. 9). A reduc-
tion of proton efﬂux would affect the extracellular pH, which has
been implicated in cancer cell invasion and migration (Andersen
et al., 2014; Bhujwalla et al., 2001). However, we did not observe
defects in DFC migration. The alteration of pH in DFCs suggests
Atp6ap1b functions cell-autonomously in these cells, but we
cannot rule out cell-nonautonomous effects. It is possible to de-
liver atp6ap1b MO to the DFC/KV cell lineage (Amack and Yost,
2004) to interfere with zygotic DFC Atp6ap1b expression, but we
know from the zygotic atp6ap1b mutants that maternal protein is
sufﬁcient for normal KV development and LR patterning. We
predict that reducing both maternal and zygotic Atp6ap1b alters
proton ﬂux that impacts the proliferation rate of DFCs that give
rise to KV. pH has been previously linked to proliferation control in
several contexts. For example, alkaline intracellular pH allows for
increased proliferation in cancer cells, whereas a reduced pH
dampens proliferation in several cell types (Aravena et al., 2012;
Che et al., 2008; Schreiber, 2005). These previous observations in
cultured cells are consistent with our in vivo observations, but
mechanisms for how pH inﬂuences DFC proliferation remain un-
clear. It is possible that ion ﬂux affects cell–cell signaling that
maintains proliferation.
V-ATPase activity is important for Wnt (Cruciat et al., 2010;
Hermle et al., 2010), Notch (Vaccari et al., 2010; Yan et al., 2009)
and mTOR (Zoncu et al., 2011) signaling pathways that can impact
proliferation and/or cilia and are each critical for establishing LR
asymmetry. Atp6ap1b may modulate V-ATPase activity in one or
several of these pathways. Proliferation and cilia defects may be
separable phenotypes that result from interfering with two in-
dependent V-ATPase functions. Alternatively, given the intricate
relationship between proliferation/cell cycle and cilia formation
(Goto et al., 2013), it is possible these phenotypes are mechan-
istically linked. First, cilia defects in KV may be caused by cell cycle
defects in the precursor DFCs. For example, an alteration or delay
in DFC cell cycle mechanics could alter the timing of cilia elon-
gation in KV. A second possibility is that Atp6ap1b regulates
V-ATPase function in a pathway that governs both proliferation
and cilia formation. As a starting point, we hypothesized At-
p6ap1b-V-ATPase function may regulate Wnt signaling. Wnt/β-
catenin is involved in both DFC proliferation and KV cilia elonga-
tion (Caron et al., 2012; Zhang et al., 2012), and the Hþ/Kþ-ATPase
regulates Wnt pathways during cilia formation and polarization in
the Xenopus organ of asymmetry (Walentek et al., 2012). Inter-
fering with Wnt/β-catenin signaling reduced expression of the
Foxj1 transcription factor, which serves as a key regulator of motile
cilia genes (Stubbs et al., 2008; Yu et al., 2008) in zebraﬁsh DFC/KV
cells and Hþ/Kþ-ATPase depleted Xenopus embryos. However,
when we assessed Foxj1a expression in DFC/KV cells, we found no
difference in the expression levels of this Wnt/β-catenin targetgene in Atp6ap1b depleted embryos as compared to controls.
Future work will be needed to test whether Atp6ap1b functions in
other signaling cascades that regulate DFC proliferation and cilia
length. The mTOR pathway has been shown to affect cell meta-
bolism and proliferation (Sarbassov and Sabatini, 2005), and de-
creased mTOR activity reduced cilia length in KV and caused LR
patterning defects (Yuan et al., 2012). Also, Notch signaling reg-
ulates KV cilia length (Lopes et al., 2010) and Wnt/planar cell po-
larity signaling is critical for polarization of cells in the organ of
asymmetry (Oteiza et al., 2010). Understanding how Atp6ap1b
interacts with these pathways in DFCs will uncover new insights
into V-ATPase activities, proliferation control, cilia development
and mechanisms of embryo left–right patterning.4. Materials and methods
4.1. Zebraﬁsh
Embryos collected from natural matings were staged as de-
scribed (Kimmel et al., 1995). Wild-type TAB and Tg(sox17:GFP)s870
zebraﬁsh were obtained from Zebraﬁsh International Resource
Center. The atp6ap1ba82ﬁsh were kindly provided by Jeffrey Gross.
4.2. Cloning, mRNA synthesis and RT-PCR
Full-length atp6ap1b and atp6v1f cDNAs were ampliﬁed from
an early embryonic mRNA pool using the Ambion Retroscript kit
and then inserted into a pCS2 vector. Constructs were veriﬁed by
sequencing and used to generate RNA in situ hybridization probes
using a DIG RNA labeling kit (Roche). Site directed mutagenesis
was used to change ﬁve nucleotides in both atp6ap1b and atp6v1f
to prevent morpholino binding. mRNA was generated from these
morpholino-resistant constructs using mMessage mMachine kit
(Ambion) for rescue experiments. RT-PCR was performed using
primers (available upon request) that amplify atp6ap1b, atp6ap1a,
atp6v0c, atp6v0d, atp6v1g and β-actin.
4.3. Microinjections
All embryo microinjections were performed between the 1-
and 4-cell stages. Morpholinos (MO) were obtained from Gene
Tools, LLC. Two translation blocking morpholinos, atp6ap1b MO-1
(5′-AACGCCGCATTCCTACTTCCGTCAT-3′) and atp6ap1b MO-2 (5′-
CCGTCATTCTGCTGGAGAGTCACGT-3′), were used at a 2 ng optimal
dose or 1 ng low dose. A translation blocking atp6v1f MO (5′-
CCGGGCATCGTGACTTTGTCTTATA-3′) was injected at 3 ng (opti-
mal) or 1 ng (low) dose. A standard negative control MO (5′-
CCTCTTACCTCAGTTACAATTTATA-3′) was injected at 3 ng dose. For
atp6ap1b MO rescue experiments, 50 pg of MO-resistant atp6ap1b
mRNA was co-injected with 2 ng atp6ap1b MO-1. For rescue of
atp6v1f MO phenotypes, 50 pg of MO-resistant atp6v1f mRNA was
co-injected with 3 ng atp6v1f MO. 4 ng of p53 MO (5′-
GCGCCATTGCTTTGCAAGAATTG-3′) was injected to prevent p53-
dependent apoptosis (Robu et al., 2007).
4.4. RNA in situ hybridizations and ﬂuorescent immunostaining
Whole mount RNA in situ hybridizations were performed as
previously described (Wang et al., 2011). For immunostaining,
embryos were ﬁxed overnight at 4 °C in 4% paraformaldehyde,
sucrose buffer (4% sucrose, 0.1 M NaPO4, 0.3 M CaCl2) and 0.5%
Triton X-100 and then processed for whole mount antibody
staining as described (Tay et al., 2013). Primary antibodies: anti-
aPKC (Santa Cruz sc-216) (1:200 dilution), anti-acetylated tubulin
(Sigma T6793) (1:400), anti-GFP (Invitrogen A11120) (1:400), anti-
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anti-ATP6AP1 (Sigma A1486) (1:200). For Atp6v1f immunostain-
ing, 4% paraformaldehydeþ0.02% Tween was used to ﬁx embryos
and the primary antibody was anti-Atp6v1a (Proteintech Group
17115-1-AP) (1:125) as described (Einhorn et al., 2012). A second
Atp6v1a antibody (GenScript JP_A00938-40) (1:100) was used to
verify staining. AlexaFluor 488, 568 and 647 ﬂuorescent secondary
antibodies (Invitrogen) were used at 1:200 dilutions. DAPI (Sigma)
(1:500) was used to stain nuclei. Embryos were imaged using a
Zeiss AxioImager M1 compound microscope or a Perkin-Elmer
Ultra View Vox spinning disk confocal microscope. When neces-
sary, images were rotated for uniform orientations.
4.5. Western blotting
Zebraﬁsh embryo protein extracts were prepared as described
(Link et al., 2006). 30 μL of 6X SDS sample buffer was added and
samples were boiled for 5 min. Approximately 60 embryos at the
bud stage (10 hpf) were loaded into each lane for MO treatments
and approximately 8 embryos at 3, 5 or 7 dpf were loaded into
each lane for analysis of atp6ap1ba82 mutants. Commercially pre-
pared 12% gels (Bio-Rad laboratories 456-1044) were run at 100 V
for 2 h. Transfers were performed at 100 V for 1 h onto a ni-
trocellulose membrane (Millipore HATF00010). Membranes were
blocked in 3% BSA in TBST over night at 4°. Anti-ATP6AP1 (Sigma
A1486) was used at 1:200 dilution in 0.3% BSA in TBST for 2h at
room temperature and then washed 315 min in TBST. Anti-
rabbit (Bio-Rad laboratories 166-2408) secondary antibodies were
used at a 1:5000 dilution in TBST for 1 h at room temperature.
Following 3 washes for 15 min in TBST, membranes were in-
cubated in ECL (Bio-Rad laboratories 170-5060) for 2 min and
imaged on a ChemiDoc MP (Bio-Rad laboratories) imager. Relative
band volumes were quantitated using ImageLab software (Bio-Rad
laboratories). Membranes were then stripped in stripping buffer
(Thermo Scientiﬁc 21059) for 15 min and blocked in 3% BSA in
TBST for 1 h. Membranes were incubated with anti-alpha tubulin
antibodies (Sigma T-6199 at 1:2000 in 0.3% BSA in TBST) for a
loading control.
4.6. Quantitative analyses of Kupffer’s vesicle and neuromasts
KV development was assessed quantitatively in embryos im-
munostained with aPKC and acetylated-tubulin antibodies at the
8 somite stage. KV cilia number and length were measured using
ImageJ software (NIH) and KV area was deﬁned by drawing a line
around the area occupied by KV cilia. Neuromast area was de-
termined by using ImageJ to draw an outline of hair cells stained
with phalloidin (1:400, Invitrogen). Neuromast kinocilia were
stained with acetylated-tubulin antibodies and the length of the
cluster was measured using ImageJ. Eight neuromasts were ana-
lyzed per embryo in Atp6ap1b mutants at 3 days and three neu-
romasts were analyzed per embryo at 5 and 7 days. For morpho-
lino treated embryos 5 neuromasts were analyzed per embryo.
4.7. Atp6v1a localization
ImageJ was used to quantify Atp6v1a staining. In DFC and EVL
cells, ﬂuorescence intensity at a plasma membrane was measured
by outlining a cell–cell boundary and an average cytoplasmic
ﬂuorescence was derived from two measurements, one from each
of the two cell’s cytoplasmic domains. For DFCs at the edge of the
cluster that did not have an adjacent DFC, only one cytoplasmic
measurement was used. Ten membranes were blindly analyzed in
each embryo. A ratio of plasma membrane to cytoplasmic signal
was used to describe the distribution of Atp6v1a. In neuromasts,
Atp6v1a distribution was analyzed by taking a ratio of Atp6v1aimmnuoﬂuorescence intensity in the basal and apical domains of
hair cells as described (Einhorn et al., 2012). Two neuromasts were
analyzed per embryo.
4.8. Concanamycin A treatments
To pharmacologically block V-ATPase activity, embryos were
placed in embryo media containing 175 nM Concanamycin Aþ1%
DMSO. Controls were treated with 1% DMSO alone. At the end of
the treatment period, embryos were removed from the drug,
rinsed with embryo media and allowed to develop until the 8 so-
mite stage for KV analysis or 2 dpf for heart looping analysis.
4.9. DFC imaging in living embryos
Live Tg(sox17:GFP) embryos injected with either control MO or
atp6ap1b MO-1 were mounted in low melting agarose at the 60%
epiboly stage to track GFPþ DFCs using time-lapse microscopy.
Images of DFCs were collected every 5 min for 2 h using a Perkin-
Elmer Ultra VIEW Vox spinning disc confocal microscope. Movies
were assembled and analyzed using Volocity and ImageJ software.
4.10. Analysis of DFC/KV cell numbers, proliferation and apoptosis
The number of DFC and KV cells was determined by manually
counting DAPI stained nuclei of GFPþ DFC/KV cells in Tg(sox17:
GFP) embryos in a Z-series of images collected using spinning disk
confocal microscopy. Manually counting pHH3þ DFCs was used to
determine percentage of proliferating DFCs in Tg(sox17:GFP) em-
bryos. Annexin V-cy5 (Life Technologies) labeling was used to
assess apoptosis (Peri and Nusslein-Volhard, 2008). As a positive
control, embryos were pre-treated with DNAse I to induce apop-
tosis. DNase I-treated or MO injected embryos were treated with
Annexin V for two hours between 60% and 80% epiboly stages and
then mounted in a 1% low melting agarose for imaging of Annexin
V labeled apoptotic cells in live Tg(sox17:GFP) embryos.
4.11. pH measurements
LysoTracker Red DND-99 (Life Technologies) was used to ana-
lyze acidic organelles. Live Tg(sox17:GFP) embryos injected with
either control MO or atp6ap1b MO-1 were treated with 70 nM
LysoTracker dye in embryo media at the 60–70% epiboly stages for
30 min. Embryos were then mounted in 1% low melting agarose
for imaging of DFCs using spinning disc confocal microscopy. Ly-
soTracker signal was quantiﬁed in ImageJ by outlining GFPþ DFCs
and then using this region of interest to measure LysoTracker
ﬂuorescence intensity. To visualize cytoplasmic pH in DFCs, Tg
(sox17:GFP) embryos were treated at 70% epiboly for 30 min with
2 μM SNARF-5F pH ﬂuorescent dye (SNARF-5F 5-(and-6)-Car-
boxylic Acid, Acetoxymethyl Ester, Acetate-Special Packaging, Life
Technologies) (Han and Burgess, 2010). Leica SP5 confocal micro-
scopy was used to capture images of the SNARF-5F dye using ex-
citation at 543 nm and dual emissions of 580 nm (pH independent
loading control) and 640 nm (pH-dependent measurement). GFP
was imaged using the 488 nm laser line excitation with emission
at 525–535 nm. Embryos were pseudo-colored using the ratio of
640/580 nm to visualize variation in ﬂuorescent intensity. To de-
termine relative pH, DFCs were outlined and the average ratio-
metric intensity was determined using the ImageJ Ratio Plus plug
in. The same region of interest was used to measure the average
640/580 nm ratio intensity in dorsal margin cells adjacent to DFCs
in the same embryo. For this analysis, a single confocal Z-section
was used at a pre-determined depth, which was set at ¼ through
the Z-series. To verify that SNARF-5F exhibits pH-dependent
ﬂuorescence in zebraﬁsh, we treated 70% epiboly embryos with
J.J. Gokey et al. / Developmental Biology 407 (2015) 115–130 129Nigericin (2 μM) and Monensin (25 μM) to equilibrate the embryo
pH to media with a pH of 5.0, 6.8 or 8.0 (Miesenbock et al., 1998)
and then imaged the whole embryo at 90% epiboly.
4.12. Statistics
The Student’s T-test was used for all statistical analyses. Dif-
ferences were considered statistically signiﬁcant if the p-value was
less than 0.05. For all graphs: * indicates po0.05; ns indicates no
signiﬁcant difference; error bars represent one standard deviation;
and n¼number of embryos analyzed.Acknowledgments
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